Market Tracker

05/23 5:16pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

17.68
Delayed Data
As of 3:59pm ET
 +0.05 / +0.28%
Today’s Change
12.51
Today|||52-Week Range
19.35
-5.76%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close17.63
Today’s open17.76
Day’s range17.32 - 17.89
Volume419,736
Average volume (3 months)628,051
Market cap$756.9M
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-2,514.29%
Earnings growth (this year)+21.05%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+41.36%
P/E ratioNM
Price/Sales1.26
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...-0.05-1.68%
RGNXRegenxbio Inc+0.50+2.76%
MEDPMedpace Holdings Inc-0.12-0.45%
BSTCBiospecifics Technol...-0.23-0.45%
Data as of 3:59pm ET, 05/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$568.8M
Annual profit (last year)-$70.2M
Net profit margin-12.34%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts